- Home
- TEVA vs NIO Comparison
TEVA vs NIO Comparison
Compare TEVA & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- NIO
- Stock Information
- Founded
- TEVA 1901
- NIO 2014
- Country
- TEVA Israel
- NIO China
- Employees
- TEVA N/A
- NIO N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- NIO Auto Manufacturing
- Sector
- TEVA Health Care
- NIO Consumer Discretionary
- Exchange
- TEVA Nasdaq
- NIO Nasdaq
- Market Cap
- TEVA 21.2B
- NIO 18.0B
- IPO Year
- TEVA N/A
- NIO 2018
- Fundamental
- Price
- TEVA $20.02
- NIO $7.45
- Analyst Decision
- TEVA Strong Buy
- NIO Buy
- Analyst Count
- TEVA 7
- NIO 9
- Target Price
- TEVA $25.57
- NIO $6.63
- AVG Volume (30 Days)
- TEVA 10.3M
- NIO 93.9M
- Earning Date
- TEVA 11-05-2025
- NIO 11-19-2025
- Dividend Yield
- TEVA N/A
- NIO N/A
- EPS Growth
- TEVA N/A
- NIO N/A
- EPS
- TEVA N/A
- NIO N/A
- Revenue
- TEVA $16,628,000,000.00
- NIO $9,690,436,500.00
- Revenue This Year
- TEVA $4.07
- NIO $37.91
- Revenue Next Year
- TEVA $0.81
- NIO $39.45
- P/E Ratio
- TEVA N/A
- NIO N/A
- Revenue Growth
- TEVA 2.08
- NIO 9.28
- 52 Week Low
- TEVA $12.47
- NIO $3.02
- 52 Week High
- TEVA $22.80
- NIO $8.02
- Technical
- Relative Strength Index (RSI)
- TEVA 61.37
- NIO 60.03
- Support Level
- TEVA $19.87
- NIO $7.50
- Resistance Level
- TEVA $20.61
- NIO $7.85
- Average True Range (ATR)
- TEVA 0.61
- NIO 0.39
- MACD
- TEVA 0.05
- NIO -0.04
- Stochastic Oscillator
- TEVA 75.12
- NIO 55.60
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.